PharmaResearch Acquires CG USA to Localize Rejuran

PharmaResearch has completed the acquisition of US cosmetic and skincare manufacturer CG USA. The primary goal of this transaction is to localize its key product, Rejuran, for the Americas market. By integrating CG USA's existing US resources, PharmaResearch aims to shorten supply chain cycles and respond more quickly to local market demands.

For brands, this move implies that Rejuran's channel deployment in the Americas will rely more on local entities. B2B buyers should note that future supply may shift from direct importation to local inventory or localized production models, potentially improving supply stability and compliance response times. Relevant brands and distributors are advised to engage with the CG USA system early to adapt to the new localized operations.